(Q37895407)

24 August 2017

1 reference

title

Nuocytes: expanding the innate cell repertoire in type-2 immunity (English)

1 reference

24 August 2017

author

Andrew N. J. McKenzie

series ordinal

2

object named as

Andrew N J McKenzie

1 reference

24 August 2017

Jillian L Barlow

1

1 reference

24 August 2017

publication date

28 June 2011

1 reference

Journal of Leukocyte Biology

24 August 2017

published in

1 reference

24 August 2017

volume

90

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

867-874

1 reference

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Immune cell crosstalk in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

The role of the T cell in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Differentiation and function of Th17 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Fate mapping of IL-17-producing T cells in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Impaired development of Th2 cells in IL-13-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

What determines Th2 differentiation, in vitro and in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Interleukin 25 promotes the initiation of proallergic type 2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Innate immune cell populations function as initiators and effectors in Th2 cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ + gut intraepithelial lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

A role for CCR9 in T lymphocyte development and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Critical role for β7 integrins in formation of the gut-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Role of beta7 integrins in intestinal lymphocyte homing and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

ICOS is essential for effective T-helper-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

ICOS co-stimulatory receptor is essential for T-cell activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

B7h is required for T cell activation, differentiation, and effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0311160

21 January 2018

Identifiers

DOI

10.1189/JLB.0311160

1 reference

24 August 2017

1 reference